| Heading: |
Attention Deficit Hyperactivity Disorder: Drugs |
| Question ID: |
1745577 |
| UIN: |
16750 |
| House: |
Commons |
| Date tabled: |
2024-11-28 |
| Asking Member ID: |
4126 |
| Asking Member display name: |
Mary Glindon
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Mary Glindon
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of supply shortages for ADHD medication on the mental health of patients. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4359 |
| Answering Member display name: |
Stephen Kinnock
|
| Answering Member handle: |
skinnock
|
| Answering Member Twitter reference: |
@skinnock
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is working closely with NHS England’s attention deficit hyperactivity disorder (ADHD) and medicines supply teams, to help resolve the supply issues and improve information for people with ADHD and clinicians.We are also supporting an indepe... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |